The doctrine of equivalents in the medtech arena
The role of the doctrine of equivalents in assessing the value of, and risks associated with, medtech patents is often overlooked. Christopher Bright and Nathan Smith of Morgan Lewis report.
Latest news
CMA reveals antitrust investigation into Essential Pharma over bipolar drug
30-11-2020
The UK Competition and Markets Authority is investigating Essential Pharma over suspicions that the pharmaceutical company contravened competition law by proposing to withdraw the supply of Priadel, a lithium-based medication for bipolar disease.
Five minutes with… Jacqueline Mulryne
26-11-2020
Regions
- The doctrine of equivalents in the medtech arena 18-11-2020
- The plausibility battleground at the EPO 09-11-2020
Sectors
